临床试验/ISRCTN20781131

ISRCTN20781131已完成未知

High-risk human papillomavirus (HrHPV) in the population research on cervical cancer: a randomised clinical trial

Vrije University Medical Centre (VUMC) (The Netherlands)0 个研究点目标入组 44,102 人开始时间: 2005年12月20日最近更新: 2022年11月14日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 44,102

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2004 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/15054873 Design, methods and baseline data: 2005 Results article in http://www.ncbi.nlm.nih.gov/pubmed/15900579 Association between higher-grade CIN and HPV type 2007 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/17919718 5-year follow-up 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22177579 Final results 2018 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/29663363 Post hoc analysis of 14-year follow-up data 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/36306283/ Association between cervical precancer risk at 14 years and previous screening results (added 31/10/2022)

研究设计

研究类型: Interventional

入排标准

性别: Female

入选标准

•1. Women invited for the cervical cancer screening program (ages 30 - 60 years)
•2. Residing in either the region covered by district health authority Amstelland-de Meerlanden and Zuid-Kennemerland

排除标准

•1. Not called for screening, ie ages under 30 years, or over 60 years
•2. Follow-up of previous non-normal cytology within the current screening round of the program, i.e., abnormal cytology or CIN lesions less than two years before inclusion
•3. Status after extirpation of the uterus or amputation of the portio

研究者

发起方

Vrije University Medical Centre (VUMC) (The Netherlands)

相似试验

Epidemiological analysis of human papillomavirus in western Kazakhstan in relation to HPV-attributable cervical pathology – social, clinical and genetic aspectsCervical cancerMalignant neoplasm of cervix uteriCancer

ISRCTN71514910Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan1,166

HrHPV in the population research on cervical cancer.Cervical intraepithelial neoplasia and cervical cancer. Due to the low prevalence of invasive cervical cancer in the Netherlands, and the aim of cervical screening to prevent the occurrence of and death caused by to cervical cancer, we evaluate the prevalence of a surrogate marker for cervical cancer incidence, namely the immediate precursor lesion of cervical cancer cervical intra-epithelial neoplasia grade 3.

NL-OMON28695- Department of Pathology, VU University Medical Center- Department of Pathology, Spaarne Ziekenhuis, Hoofddorp- Leiden Cytology and Pathology Laboratory, Leiden- Stichting PA Laboratorium Kennemerland, Haarlem44,102

Human papillomavirus (HPV) vaccine in human immunodeficiency virus (HIV) positive girls and womeHuman immunodeficiency virus, human papillomavirusInfections and InfestationsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

ISRCTN33674451Women's Health Research Institute (WHRI) (Canada)500

Epidemiological studies on human papillomavirus (HPV)

ISRCTN90378590ondon School of Hygiene & Tropical Medicine (UK)330

Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod TreatmentHPV

NCT00941811Medical University of Vienna5